Caisse Des Depots Et Consignations’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.29M Sell
344,210
-17,281
-5% -$452K 0.14% 46
2026
Q1
$10.2M Buy
361,491
+9,914
+3% +$264K 0.17% 34
2025
Q4
$8.75M Hold
351,577
0.2% 42
2025
Q3
$8.96M Buy
351,577
+18,001
+5% +$444K 0.38% 39
2025
Q2
$8.09M Buy
333,576
+33,912
+11% +$791K 0.34% 46
2025
Q1
$7.59M Sell
299,664
-5,025
-2% -$131K 0.37% 45
2024
Q4
$8.08M Buy
+304,689
New +$8.26M 0.4% 36

Other funds holding PFE

Caisse Des Depots Et Consignations's PFE Position: Q2 2026 in Review

Caisse Des Depots Et Consignations reduced its Pfizer (PFE) stake by 4.8% in Q2 2026, selling an estimated $452K and leaving 344,210 shares worth $8.29M. The position accounts for 0.14% of the portfolio, ranked #46.

Caisse Des Depots Et Consignations first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $10.2M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Caisse Des Depots Et Consignations held 344,210 shares of Pfizer worth $8.29M as of Q2 2026.
  • Caisse Des Depots Et Consignations sold 17,281 Pfizer shares in Q2 2026, an estimated $452K.
  • Pfizer made up 0.14% of Caisse Des Depots Et Consignations's portfolio in Q2 2026, its #46 holding.
  • Caisse Des Depots Et Consignations first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Caisse Des Depots Et Consignations's Pfizer position peaked at $10.2M in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Caisse Des Depots Et Consignations's 13F filing for Q2 2026, filed 24 Jul 2026.